Vascular endothelial growth factor expression in pN2 non-small cell lung cancer: Lack of prognostic value

Respirology

Volumn 10, Issue 1, 2005, Pages 31-35

  Tomita, Masaki ^a   Matsuzaki, Yasunori ^a   Shimizu, Tetsuya ^a   Hara, Masaki ^a   Ayabe, Takanori ^a   Onitsuka, Toshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Non small cell lung cancer; pN2; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 14844286511     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00655.x     Document Type: Article

References (18)

1. Regnard JF, Magdeleinat P, Azoulay D et al. Results of resection for bronchogenic carcinoma with mediastinal lymph node metastases in selected patients. Eur. J. Cardiothorac. Surg. 1991; 5: 583-6.
2. Maggi G, Casadio C, Cianci R et al. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases. Int. Surg. 1993; 78: 213-17.
3. Goldstraw P, Mannam GC, Kaplan DK, Michail P. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J. Thorac. Cardiovasc. Surg. 1994; 107: 19-27.
4. Riquet M, Manac'h D, Saab M, Le Pimpec-Barthes F, Dujon A, Debesse B. Factors determining survival in resected N2 lung cancer. Eur. J. Cardiothorac. Surg. 1995; 9: 300-4.
5. Vansteenkiste JF, De Leyn PR, Deneffe GJ et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group. Ann. Thorac. Surg. 1997; 63: 1441-50.
6. Yano T, Fukuyama Y, Yokoyama H et al. Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection. Eur. J. Cardiothorac. Surg. 1998; 14: 152-5.
7. Sagawa M, Sakurada A, Fujimura S et al. Five-year survivors with resected pN2 nonsmall cell lung carcinoma. Cancer 1999; 85: 864-8.
8. Gabrilovich DI, Chen HL, Girgis KR et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 1996; 2: 1096-103.
9. Herold-Mende C, Steiner HH, Andl T et al. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells. Lab. Invest. 1999; 79: 1573-82.
10. Arbiser JL, Larsson H, Claesson-Welsh. L et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am. J. Pathol. 2000; 156: 1469-76.
11. Baek JH, Jang JE, Kang CM, Chung HY, Kim ND, Kim KW. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 2000; 19: 4621-31.
12. Han H, Silverman JF, Santucci TS et al. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann. Surg. Oncol. 2001; 8: 72-9.
13. Giatromanolaki A, Koukourakis MI, Kakolyris S et al. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Clin. Cancer Res. 1998; 4: 3017-24.
14. Yuan A, Yu CJ, Kuo SH et al. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J. Clin. Oncol. 2001; 19: 432-41.
15. Liao M, Wang H, Lin Z, Feng J, Zhu D. Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer. Lung Cancer 2001; 33: 125-32.
16. Baillie R, Carlile J, Pendleton N, Schor AM. Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer. J. Clin. Pathol. 2001; 54: 116-20.
17. Dziadziuszko R, Chyczewski L, Jassem E, Jassem J. Expression of vascular endothelial growth factor (VEGF) and its receptor FLK-1 in non-small cell lung cancer (NSCLC) - a preliminary report. Folia Histochem. Cytobiol. 2001; 39 (Suppl. 2): 100-1.
18. Takahama M, Tsutsumi M, Tsujiuchi T et al. Frequent expression of the vascular endothelial growth factor in human non-small-cell lung cancers. Jpn. J. Clin. Oncol. 1998; 28: 176-81.